Bank of Ann Arbor’s Edwards Lifesciences EW Stock Holding History

Bank of Ann Arbor’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$104K	Buy	+1,200	New	+$107K	0.01%	258

Other funds holding EW

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Bank of Ann Arbor's EW Position: Q3 2026 in Review

Bank of Ann Arbor opened a new position in Edwards Lifesciences (EW) in Q3 2026: 1,200 shares worth $104K. The stake represents 0.01% of the portfolio and ranks #258 among its holdings.

1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Bank of Ann Arbor held 1,200 shares of Edwards Lifesciences worth $104K as of Q3 2026.
Edwards Lifesciences was a new Bank of Ann Arbor position in Q3 2026.
Edwards Lifesciences made up 0.01% of Bank of Ann Arbor's portfolio in Q3 2026, its #258 holding.
1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Bank of Ann Arbor's 13F filing for Q3 2026, filed 13 Nov 2026.